Suppr超能文献

家族性淀粉样多神经病患者的继发性青光眼。

Secondary glaucoma in patients with familial amyloidotic polyneuropathy.

作者信息

Kimura Akira, Ando Eiko, Fukushima Mikiko, Koga Takahisa, Hirata Akira, Arimura Kazue, Ando Yukio, Negi Akira, Tanihara Hidenobu

机构信息

Department of Ophthalmology, Kumamoto University School of Medicine, 1-1-1 Honjo, Kumamoto 860-8556, Japan.

出版信息

Arch Ophthalmol. 2003 Mar;121(3):351-6. doi: 10.1001/archopht.121.3.351.

Abstract

OBJECTIVE

To elucidate the clinical features and surgical outcomes of the treatment of secondary glaucoma associated with transthyretin (TTR)-related familial amyloidotic polyneuropathy (FAP).

DESIGN

Retrospective case study.

PARTICIPANTS

Forty-nine Japanese patients with FAP.

METHODS

For all patients, measurement of best-corrected visual acuity, intraocular pressure, and visual fields as well as slitlamp and ocular fundus examinations were conducted and compared. In addition, the exact mutation of the amyloidogenic TTR variants was analyzed for all 49 patients with FAP. The TTR mutations included amyloidogenic TTR (ATTR) Val30Met in 41 patients, ATTR Tyr114Cys in 6, ATTR Ser50Ile in 1, and a compound heterozygous mutation of ATTR Val30Met + Arg104His in 1.

RESULTS

The onset of secondary glaucoma was defined as elevation of intraocular pressure and glaucomatous changes in visual field defects. Secondary glaucoma was detected in 12 (24%) of the 49 patients. The incidence of secondary glaucoma in patients with the Val30Met mutation (17%) was lower than for the other FAP genotypes (P =.02 using the chi(2) test). Of 20 glaucomatous eyes, amyloid deposition on the pupil and anterior surface of the lens was found in 18 eyes. Amyloid deposition was found prior to glaucoma in 11 eyes and at the first visit to our clinic in another 7 eyes. In the 11 eyes in which the onset of glaucoma occurred following amyloid deposition along the pupil, the mean +/- SD period between the onsets of pupillary amyloid deposition and glaucoma was 2.55 +/- 1.43 years (range, 0.2-4.0 years). Further statistical analyses revealed significant relationships between the onset of secondary glaucoma and both amyloid deposition (P<.001) and vitreous opacity (P<.001). Surgical treatment was required in 15 (75%) of the 20 glaucomatous eyes. In 9 (81%) of the 11 eyes that underwent trabeculectomy, the intraocular pressure was well controlled at or lower than 20 mm Hg during the follow-up period. In the eyes that underwent combined trabeculotomy and sinusotomy (2 eyes), nonpenetrating trabeculectomy (1 eye), or a cyclodestructive procedure (1 eye), the intraocular pressure was poorly controlled.

CONCLUSIONS

Glaucoma is not a rare condition in patients with FAP, especially because liver transplantation now enables patients with FAP to live longer. Careful observation of amyloid deposition along the pupil allows the prediction of glaucoma onset.

摘要

目的

阐明与转甲状腺素蛋白(TTR)相关的家族性淀粉样多发性神经病(FAP)相关的继发性青光眼的临床特征和手术效果。

设计

回顾性病例研究。

参与者

49例日本FAP患者。

方法

对所有患者进行最佳矫正视力、眼压、视野测量以及裂隙灯和眼底检查,并进行比较。此外,对所有49例FAP患者分析了淀粉样TTR变体的具体突变情况。TTR突变包括41例患者中的淀粉样TTR(ATTR)Val30Met、6例中的ATTR Tyr114Cys、1例中的ATTR Ser50Ile以及1例中的ATTR Val30Met + Arg104His复合杂合突变。

结果

继发性青光眼的发病定义为眼压升高和视野缺损出现青光眼性改变。49例患者中有12例(24%)检测到继发性青光眼。Val30Met突变患者的继发性青光眼发病率(17%)低于其他FAP基因型患者(采用卡方检验,P = 0.02)。在20只青光眼眼中,18只眼在瞳孔和晶状体前表面发现淀粉样沉积。11只眼在青光眼发生前发现淀粉样沉积,另外7只眼在首次就诊时发现。在11只沿瞳孔出现淀粉样沉积后发生青光眼的眼中,瞳孔淀粉样沉积与青光眼发病之间的平均±标准差时间为2.55±1.43年(范围,0.2 - 4.0年)。进一步的统计分析显示继发性青光眼的发病与淀粉样沉积(P < 0.001)和玻璃体混浊(P < 0.001)均存在显著相关性。20只青光眼眼中有15只(75%)需要手术治疗。在接受小梁切除术的11只眼中,有9只(81%)在随访期间眼压得到良好控制,眼压在20 mmHg或更低。在接受小梁切开术联合鼻窦切开术(2只眼)、非穿透性小梁切除术(1只眼)或睫状体破坏手术(1只眼)的眼中,眼压控制不佳。

结论

青光眼在FAP患者中并不罕见,尤其是因为肝移植现在使FAP患者能够活得更长。仔细观察瞳孔周围的淀粉样沉积有助于预测青光眼的发病。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验